Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes
JAMAPublished 24 July 2002
Cynthia A. Jackevicius
Citations1,077
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Elderly patients with and without recent ACS have low rates of adherence to statins, which suggests that many patients initiating statin therapy may receive no or limited benefit from statins because of premature discontinuation.
Abstract
Elderly patients with and without recent ACS have low rates of adherence to statins. This suggests that many patients initiating statin therapy may receive no or limited benefit from statins because of premature discontinuation.
Keywords
MedicineEconomics, Econometrics and Finance
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
New England Journal of MedicineThe Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
7,491 Citations1996Frank M. Sacks, Marc A. Pfeffer +10 more
It is demonstrated that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels and was also greater in patients with higher pretreatment levels of LDL cholesterol.
New England Journal of MedicinePrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
7,453 Citations1995James Shepherd, Stuart M. Cobbe +6 more
Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
New England Journal of MedicinePrevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
5,299 Citations1998The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespecified cardiovascular events in patients with a history of myocardial infarction or unstable angina who had a broad range of initial cholesterol levels.
JAMAPrimary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
5,269 Citations1998John R. Downs, Michael Clearfield +8 more
Lovastatin reduces the risk for the first acute major coronary event in men and women with average TC and LDL-C levels and below-average HDL- C levels and supports the inclusion of HDL-C in risk-factor assessment and the need for reassessment of the National Cholesterol Program guidelines.
JAMAEffects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2,493 Citations2001Gregory G. Schwartz
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes and the MIRACL study are studied.
Journal of Clinical EpidemiologyThe assessment of refill compliance using pharmacy records: Methods, validity, and applications
1,183 Citations1997John F. Steiner, Allan V. Prochazka
It is concluded that, though some methodologic problems require further study, RC measures can be a useful source of compliance information in population-based studies when direct measurement of medication consumption is not feasible.
The American Journal of CardiologyComparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
1,073 Citations1998Peter J.H. Jones, Stephanie D. Kafonek +2 more
The objective of this multicenter, randomized, open-label, parallel-group, 8-week study was to evaluate the comparative dose efficacy of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor atorvastatin 10, 20, 40, and 80 mg.
Annals of Internal MedicineUnderstanding and Improving Patient Compliance
794 Citations1984Stephen A. Eraker, JOHN P. KIRSCHT +1 more
The problem of patient compliance, as well as the ability of the physician to understand, detect, and improve compliance are described in relation to a new model of health decisions and patient behavior.
JAMAPersistence of Use of Lipid-Lowering Medications
639 Citations1998Jerry Avorn, Johanne Monette +5 more
JAMAEarly Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
532 Citations2001Ulf Stenestrand
CirculationWithdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes
484 Citations2002Christopher Heeschen, Christian W. Hamm +4 more
Statin pretreatment in patients with acute coronary syndromes is associated with improved clinical outcome, however, discontinuation of statin therapy after onset of symptoms completely abrogates this beneficial effect.
New England Journal of MedicineDiscontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?
380 Citations1995Susan E. Andrade, Alexander M. Walker +5 more
The effectiveness and tolerability of antihyperlipidemic medications should be studied further in populations that typically use the agents, and in open-label studies were similar to those in the HMOs.
Archives of Internal MedicineRecall of Recommendations and Adherence to Advice Among Patients With Chronic Medical Conditions
377 Citations1993Richard L. Kravitz
The majority of chronically ill patients failed to recall elements of potentially important medical advice and did not always adhere to advice that was recalled, and self-reported adherence was correlated with clinical measures of disease activity and control.
The LancetEffect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
315 Citations2001Herbert D. Aronow, Eric J. Topol +13 more
Prescription of a lipid-lowering drug at hospital discharge was independently associated with reduced short-term mortality among patients after an acute coronary syndrome.
The Medical Journal of AustraliaApparent discontinuation rates in patients prescribed lipid‐lowering drugs
213 Citations1996Leon A. Simons, Graham Levis +1 more
Evaluation of apparent discontinuation rates in patients newly prescribed lipid‐lowering drugs finds no clear pattern in response to lipid-lowering medications.
ACC Current Journal ReviewEffects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. the miracl study: a randomized controlled trial
153 Citations2001Gregory G. Schwartz, Anders Olsson +1 more
For patients with acute coronary syndrome, lipid-lowering therapy with atorvastatin, 80 mg/d, reduces recurrent ischemic events in the first 16 weeks, mostly recurrent symptomatic ischemia requiring rehospitalization.
Journal of Cardiopulmonary RehabilitationUSEFULNESS OF IN-HOSPITAL PRESCRIPTION OF STATIN AGENTS AFTER ANGIOGRAPHIC DIAGNOSIS OF CORONARY ARTERY DISEASE IN IMPROVING CONTINUED COMPLIANCE AND REDUCED MORTALITY
150 Citations2001&NA;
PharmacoEconomicsThe Influence of Hospital-Based Prescribers on Prescribing in General Practice
92 Citations1999J. Feely, Robert Chan +2 more
It is indicated that hospital-initiated prescriptions are responsible for a significant proportion, both in volume and cost of GP prescribing.
European Heart JournalCompliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study
82 Citations1997The West of Scotland Coronary Prevention Study Group
The analysis of the effect of pravastatin in the subgroup of high compliers to randomized medication demonstrated a substantial increase in the estimated risk reductions in comparison with that achieved in the intention-to-treat analysis.
PubMedDiscontinuation rates of cholesterol-lowering medications: implications for primary care.
79 Citations1999Hiatt Jg, Shamsie Sg +1 more
Despite initiation of niacin and sequestrant therapy in the setting of a multidisciplinary lipid clinic, drug discontinuation rates were high and were similar to rates observed in primary-care settings.
The LancetRate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarction
73 Citations2000Paula A. Rochon, Jack V. Tu +7 more
Archives of Internal MedicineRecall of recommendations and adherence to advice among patients with chronic medical conditions
65 Citations1993R. L. Kravitz
Archives of Internal MedicineUse of the Statins in Patients After Acute Myocardial Infarction
64 Citations2001Cynthia A. Jackevicius, George Anderson +2 more
It is found that it is possible to shift practice if the evidence of benefit is strong, the intervention is easy to implement, and the Intervention is marketed aggressively.
Journal of Internal MedicineCompliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid‐lowering in primary care
60 Citations1998Mats Eriksson, Karin Hådell +3 more
Results from other studies indicate that there also might be other positive effects of statin treatment beyond cholesterol lowering, and suggest that an increase in the dosage of the HMG-CoA reductase inhibitor may be appropriate.
The American Journal of CardiologyEffect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction
53 Citations2001Kevin A. Bybee, R. Scott Wright +4 more
End points of in-hospital mortality and in- hospital reinfarction were significantly lower in the statin-treated group, pointing to a benefit from very early statin treatment in acute myocardial infarction.
ACC Current Journal ReviewEarly statin treatment following acute myocardial infarction and 1-year survival
28 Citations2001Ulf Stenestrand, Lars Wallentin
Early initiation of statin treatment in patients with AMI is associated with reduced 1-year mortality, and the importance of implementing the results of randomized statin trials in unselected AMI patients is emphasized.
Cardiology in ReviewCompliance with Antihypertensive Therapy
19 Citations1994Peter Rudd
The emergence of improved dynamic measures of medication-taking behavious has helped shift the paradigm to a more useful level and a spectrum of preventive, remedial and maintenance maneuvers is available to optimize compliance with antihypertensive therapy.